Friday | April 24, 2015
7:00am – 5:30pm
Registration Open | Liberty Ballroom Foyer
12:00pm – 7:00pm
Poster Session Open | Freedom Ballroom
8:30am – 9:30am
Updated Insights in Psoriatic Diseases & Breakfast | Jeremy Moss, MD, PhD | Presented by Abbvie | Liberty C/D Ballroom
9:35am – 10:20am
Perspectives in the Management of Early Stage (IA and IB) MF-CTCL: Current Concepts in Clinical Practice | Stuart R. Lessin, MD | Presented by Actelion | Liberty C/D Ballroom
10:20am – 10:35am
Break | Sponsored by Genentech
10:35am – 11:20am
Treating Advanced Basal Cell Carcinoma Through Hedgehog Pathway Inhibition | Leon Kircik, MD | Presented by Genentech | Liberty C/D Ballroom
11:30am – 12:30pm
Psoriasis in the Diverse US Population & Lunch | Joseph Jorizzo, MD | Presented by Amgen | Liberty C/D
12:00pm – 7:00pm Exhibit Hall Open | Independence Ballroom
12:55pm – 1:05pm
Conference Welcome | Mark Abdelmalek, MD, Overall Chairperson | Liberty Ballroom A/B
Scientific Sessions | Moderators: Jason Lee, MD and Joslyn S. Kirby, MD | Liberty Ballroom A/B
1:05pm – 1:20pm
Acne & Rosacea Update
Newer issues regarding acne and rosacea will be discussed.
Guy Webster, MD, PhD, Clinical Professor, Jefferson Medical College, Philadelphia, PA.
1:20pm – 1:35pm
Not If, But Rather What to Screen For Psoriasis Patients On Immunosuppressive Therapies
This talk will review the recommended screening of patients prior to initiating immunosuppressive medications such as the biologics and will include discussion of how to handle various vaccinations, general health recommendations, screening for hepatitis, HIV disease, and tuberculosis.
Abby S. Van Voorhees, MD, Associate Professor, Director of Psoriasis and Phototherapy Center, Department of Dermatology, University of Pennsylvania, Philadelphia, PA and Chair, Medical Board, National Psoriasis Foundation, Medical Editor, Dermatology World, American Academy of Dermatology.
1:35pm – 1:50pm
Cardiovascular Risk in Psoriasis: Implications For Your Clinical Practice
Psoriasis is associated with an increased risk of cardiovascular disease independent of traditional cardiovascular risk factors culminating in 5 years of life lost. The current data establishing psoriasis as a cardiovascular disease risk factor will be reviewed as will the impact of psoriasis treatments on cardiovascular disease.
Joel M. Gelfand MD, MSCE, Associate Professor of Dermatology and Epidemiology, and Medical Director, Dermatology Clinical Studies Unit, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
1:50pm – 2:05pm
Frontiers in Dermatology
The initial event in atopic dermatitis is occlusion of eccrine ducts with staphylococcal derived biofilms. This causes activation of TLR2 that initiates an inflammatory cascade. Evidence for streptococcus being the antigen in psoriasis causing upregulation of soluble TLR2 will be presented.
Herbert B. Allen MD, Professor and Chair of Dermatology at Drexel University College of Medicine, Philadelphia, PA.
2:05pm – 2:15pm
Question & Answer
2:15pm – 2:35pm
What’s New in Pediatric Dermatology
Review of new and emerging pediatric dermatologic diseases.
James R. Treat, MD, Assistant Professor of Pediatrics and Dermatology at the Perelman School of Medicine at the University of Pennsylvania, and Fellowship Director, Pediatric Dermatology, Children’s Hospital, Philadelphia, PA.
2:35pm – 2:55pm
Cutaneous Lupus Erythematosus: New Developments in Pathogenesis and Treatment
New insights into the pathogenesis and treatment of cutaneous lupus erythematosus will be discussed. Validated disease severity tools, an awareness of the impact of disease activity on quality of life, and the development of new immunomodulatory and biologic therapies are changing the treatment of patients with previously refractory disease.
Victoria P. Werth, MD, Professor of Dermatology and Medicine at the Perelman School of Medicine at the University of Pennsylvania and Chief of Dermatology, Philadelphia VA Medical Center, Philadelphia, PA.
2:55pm – 3:15pm
What’s New in Pemphigus Therapy?
Anti-CD20 B-cell depletion has shown outstanding efficacy in the treatment of pemphigus, although questions about safety and optimal dosing remain. In this session we will discuss the successes and challenges with anti-CD20 B-cell depletion for pemphigus and novel therapeutic strategies that are currently in development for this devastating disease.
Aimee S. Payne, MD, PhD, The Albert M. Kligman Assistant Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
3:15pm – 3:20pm
AAD Update
Our specialty faces many problems and challenges, but if we take the proper steps, we can prevent many of those problems and correct many others. I will discuss ways in which dermatologists can effectively protect our ability to provide the best dermatologic care possible to our patients.
Mark Lebwohl, MD, The Sol and Clara Kest Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at the lcahn School of Medicine at Mount Sinai, New York, NY.
3:20pm – 3:30pm
Question & Answer
3:30pm – 3:50pm
Refreshment Break & Visit the Exhibits | Independence Ballroom
Scientific Sessions | Moderators: George Cotsarelis, MD, and and Joslyn S. Kirby, MD | Liberty Ballroom A/B
3:50pm – 4:10pm
How to Read a Paper: Common Sense and Statistics
An understanding of biostatistics is invaluable when reading the medical literature. There are many statistical terms in the journals we read on a regular basis. An understanding of these terms is critical when reading the literature so that we can understand whether the results were due to chance and whether the change is clinically important. Emphasis will be on defining and applying common statistical terms. Articles from the dermatology literature will be used as examples.
Joslyn S. Kirby, MD, MS, Associate Professor of Dermatology, Vice Chair of Education, and Associate Program Director at the Penn State Milton S. Hershey Medical Center, Hershey, PA.
4:10pm – 4:30pm
Vasculitis: A Practical Approach to Diagnosis and Management
The session is a case-based discussion of the cutaneous manifestations of dermatology-relevant vasculitides, the appropriate work-up for systemic manifestations of vasculitis, and the coordination of care with colleagues in internal medicine. Appropriate screening, treatment, and monitoring of patients will be reviewed, with treatment pearls focused on cutaneous manifestations of vasculitis.
Robert G. Micheletti, MD, Assistant Professor of Dermatology and Medicine, Director of the Cutaneous Vasculitis Clinic in the Penn Vasculitis Center, and Director of the Cutaneous Graft Versus Host Disease Clinic at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
4:30pm – 4:50pm
HHV 6 and 7: Pathogenic In DRESS Syndrome?
The DRESS syndrome will be reviewed and the relationship of HHV 6 and HHV 7 infections to the pathogenesis of the DRESS syndrome will be explored. The implications of these findings regarding diagnosis and management of the DRESS syndrome will be discussed.
Warren R. Heymann, MD, Professor of Medicine and Pediatrics, Head, Division of Dermatology, Cooper Medical School of Rowan University, Clinical Professor of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA.
4:50pm – 5:05pm
HIV Dermatology in the Modern Era: Practical Tips for the General Dermatologist
This session will (1) highlight emerging topics and controversies in HIV dermatology, (2) review diagnostic and therapeutic pitfalls dermatologists may encounter in treating patients with HIV, and (3) provide evidence-based guidelines for the management of HIV-infected individuals.
Misha M. Mutizwa, MD, Assistant Professor of Dermatology at the Temple University School of Medicine and Director of HIV Dermatology at Temple University Hospital, Philadelphia, PA.
5:05pm – 5:20pm
Clinical Cases of Chronic Itch and Their Management
Chronic itch has significant impact on quality of life of millions of patients with skin diseases, advanced aging as well as systemic diseases and neuropathic and psychogenic causes. Recent advances in pruritus research have revolutionized the field with discovery of new receptors and neuronal pathways in the skin. In many types of chronic itch there is chronic hypersensitization of the neural system aggravating itch. This lecture will cover clinical cases of different types of chronic itch and treatment strategies with particular emphasize on targeting the neural system and use of novel treatment approaches.
Gil Yosipovitch, MD, Professor and Chair of Department of Dermatology at Temple University School of Medicine and Director of Temple Itch Center, Philadelphia, PA.
5:20pm – 5:30pm
Question & Answer
Welcome Reception in Exhibit Hall
Join us in thanking our sponsors for supporting Atlantic Derm!
Independence Ballroom
Friday, April 24, 2015
5:30pm - 7:00pm
Saturday | April 25, 2015
7:30am – 9:00am
Continental Breakfast at Patient Viewing | Penn Medicine Washington Square |
Round-trip Shuttle 7:00am - 11:30am
8:00am – 11:00am
Live Patient Viewing | Penn Medicine Washington Square |
Round-trip Shuttle 7:00am - 11:30am
11:00am – 11:30am
Visit the Exhibits | Independence Ballroom
11:30am – 1:00pm
Luncheon & Keynote | Liberty Ballroom C/D
Atlantic Derm Conference Update | Jeffery J. Miller, MD
Jeffrey J. Miller, MD, Professor and Chair, Department of Dermatology, Penn State Milton S. Hershey Medical Ctr., Hershey, PA.
2016 Baltimore Atlantic Derm Meeting | Sewon Kang, MD
The 2016 Atlantic Dermatological Conference will be held in the charming city of Baltimore, Maryland. We are excited to organize this wonderful conference and promise to make it not only outstandingly educational, but also socially enriching.
Sewon Kang, MD, The Noxell Professor and Chair of Dermatology at Johns Hopkins School of Medicine, Baltimore, MD.
Keynote | Raoul Wallenberg: A Personal Story of Rescue
The heroic Swedish diplomat, Raoul Wallenberg, 32 years old, left his wealthy family in Sweden in 1944 and worked in Budapest, Hungary, during WWII to save the lives of over 100,000 Jews from Nazi extermination. He disappeared on January 17, 1945, kidnapped from his diplomatic post by the Russians and then held in Moscow, in Lubyanka prison, for decades under torturous conditions. In 1983, at the request of Wallenberg’s brother, Morris Wolff, a young Philadelphia lawyer, took on the case, pro bono, to gain his release. After winning a lawsuit in U.S. Federal Court against the Russian Government demanding damages and Wallenberg’s release, his mission was frustrated and Wallenberg was never released.
Morris Wolff, Esquire, is an acclaimed international human rights lawyer and humanitarian.
1:00pm – 1:30pm
Visit the Exhibits | Independence Ballroom
1:30pm – 3:00pm
Patient Viewing Panel Discussion, part I | Liberty Ballroom A/B
Patient Viewing Panel
Misha A. Rosenbach, MD, Assistant Professor of Dermatology and Internal Medicine and Associate Program Director of the Dermatology Residency Program at the University of Pennsylvania, Philadelphia, PA.
James R. Treat, MD, Assistant Professor of Pediatrics and Dermatology at the Perelman School of Medicine at the University of Pennsylvania, and Fellowship Director, Pediatric Dermatology, Children’s Hospital, Philadelphia, PA.
Warren R. Heymann, MD, Professor of Medicine and Pediatrics, Head, Division of Dermatology, Cooper Medical School of Rowan University, Clinical Professor of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA.
Ellen J. Kim, MD, The Sandra J. Lazarus Associate Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Carrie Ann R. Cusack, MD, Associate Professor of Dermatology, Residency Director at Drexel University College of Medicine, Philadelphia, PA.
Joya Sahu, MD, Assistant Professor of Dermatology, Pathology and Medical Oncology at Thomas Jefferson University, Philadelphia, PA.
William D. James, MD, Vice-Chairman and Paul R. Gross Professor of Dermatology, Department of Dermatology, University of Pennsylvania, Philadelphia, PA.
Joslyn S. Kirby, MD, MS, Associate Professor of Dermatology, Vice Chair of Education, and Associate Program Director at the Penn State Milton S. Hershey Medical Center, Hershey, PA.
3:00pm – 3:20pm
Refreshment Break & Visit the Exhibits | Independence Ballroom
3:20pm – 5:30pm
Patient Viewing Discussion, part II | Liberty Ballroom A/B
7:00pm – 11:00pm
Reception, Dinner & Dancing | The Barnes Foundation | Double Decker Bus Round-trip Shuttle from 5:45pm - 11:30pm
Sunday | April 26, 2015
Scientific Sessions | Moderators: Lisa K. Pappas-Taffer, MD, and Temitayo A. Ogunleye, MD | Liberty Ballroom A/B
8:00am – 8:15am
Nail Unit Biopsy Techniques for Optimal Evaluation of Inflammatory Disorders
This lecture will educate attendees on a variety of methods to safely biopsy nail unit inflammatory disorders and minimize the risk of subsequent nail dystrophy. Basic and advanced methods will be covered so there will be value for dermatologists with a wide range of surgical skills.
Adam I. Rubin, MD, Assistant Professor of Dermatology, Pediatrics, and Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, The Children’s Hospital, Philadelphia, at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
8:15am – 8:30am
Dermatopathology Update
This session will provide an update in clinical dermatopathology pertinent to the practicing dermatologist. Relevant topics from the dermatology literature will be included.
Rosalie Elenitsas, MD, The Herman Beerman Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
8:30am – 8:45am
Dermatoscopy: When Is It Useful and When Is It Not?
Dermatoscopy has been touted to be useful in diagnosing skin diseases from just about every category, whether inflammatory, neoplastic, and infectious. Except for pigmented lesions, most claims of utility of dermatoscopy are based on case reports and series and are not grounded in hard science. Critical assessment on the utility of dermatoscopy will be highlighted in this session emphasizing skin diseases in which it provides diagnostic advantages in everyday clinical practice.
Jason Lee, MD, Professor, Clinical Vice Chair, Residency Director, Director of Dermatopathology, Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA.
8:45am – 9:00am
When to Transplant a Patient with a History of Skin Cancer
Solid organ transplant recipients with squamous cell carcinoma have higher rates of metastases and lower overall survival compared to the immunocompetent population. What about the patient in need of an organ who has a history of squamous cell carcinoma, particularly one that has been diagnosed as a high-risk lesion? How long should this patient have to wait prior to transplantation so as to prevent the futile expenditure of scarce donor organs? This session will address the concept of organ stewardship and review the findings of the workgroup of the International Skin Cancer Collaborative.
Christina Lee Chung, MD, Assistant Professor of Dermatology at Drexel University College of Medicine, Philadelphia, PA.
9:00am – 9:15am
New Understanding of Androgenetic Alopecia
What roles do hair follicle stem cells and prostaglandin play in androgenetic alopecia? I will present our findings showing that hair follicle stem cells are preserved in balding scalp and that prostaglandin D2 is elevated in bald scalp and inhibits nail growth.
George Cotsarelis, MD, The Milton B. Hartzell Professor and Chair of the Department of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
9:15am – 9:30am
Question & Answer
Scientific Sessions | Moderators: Emily Y. Chu, MD, PhD, and Temitayo A. Ogunleye, MD | Liberty Ballroom A/B
9:30am – 9:45am
Advances in Systemic Therapy for Melanoma
Recent advances have led to new drug approvals and improved survival in patients with advanced melanoma. An overview of novel immune therapies, efficacy, toxicity and future directions.
Tara C. Gangadhar, MD, Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
9:45am – 10:00am
Looking Beyond Thickness in Melanoma Management
The past few years have seen significant advances in treating metastatic melanoma. This session will discuss these newer treatments, including immunomodulators, such as ipilimumab and pembrolizumab, as well as BRAF inhibitors or other targeted therapy, such as vemurafenib, dabrafenib, and trametinib. Issues of relevance to dermatologists will be emphasized.
Michael E. Ming, MD, MSCE, Associate Professor of Dermatology and Director of the Pigmented Lesion Clinic at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
10:00am – 10:15am
Genetic Testing For Melanoma: An Update
Genetic and molecular testing is playing an increasing role in the management of melanoma patients. We will discuss the types of tests that are available, and clinical scenarios in which such testing is beneficial.
Emily Y. Chu, MD, PhD, Assistant Professor of Dermatology and Associate Director of the Pigmented Lesion Clinic at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
10:15am – 10:30am
Practical Issues in the Management of Melanoma
Melanomas at specialty locations often present challenges for conventional surgery. This lecture will illustrate common characteristics of melanomas that may require modification of conventional surgery.
Christopher J. Miller, MD, Assistant Professor of Dermatology, Director Penn Dermatologic Surgery, Director Penn Cutaneous Oncology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
10:30am – 10:40am
Question & Answer
Scientific Sessions | Moderators: Clifford Perlis, MD, MBe, and Temitayo A. Ogunleye, MD | Liberty Ballroom A/B
10:55am – 11:10am
Activation of Innate Immunity to Treat CTCL
The malignant T-cell in CTCL has been characterized as a CD4+ T-cell with the capacity to induce immune dysregulation. Evidence has emerged that immune potentiator therapy, particularly in a multimodality approach, can produce high response rates for all stages. The interplay between the malignant cell and the host immune response and treatment will be discussed.
Alain H. Rook, MD, Professor of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
11:10am – 11:25am
The Challenges of Managing Advanced CTCL
Thirty percent of cutaneous T-cell lymphoma patients will have advanced disease (tumor, erythrodermic, or systemic involvement) that requires more than skin directed therapies. This session will highlight the multidisciplinary approach to managing advanced stage patients including systemic therapies, stem cell transplant, as well as management of infections and secondary malignancies.
Ellen J. Kim, MD, The Sandra J. Lazarus Associate Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
11:25am – 11:35am
Question & Answer
11:35am – 11:50am
A 3-D Approach to Facial Rejuvenation
Facial rejuvenation techniques have evolved into a re-volumizing whole face approach for a three dimensional, more natural, youthful look. Injections of hyaluronic acid, calcium hydroxylapatite and poly-L-lactic acid fillers can re-establish the structural support lost by age-related soft tissue changes. Injections of botulinum toxin A complement can prolong the results of fillers by relaxing hyperkinetic muscles where fillers have been injected.
Anthony V. Benedetto DO, FACP, Clinical Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Section Chief, Department of Medicine, Mercy Fitzgerald Hospital, Darby, PA and Medical Director, Dermatologic SurgiCenter, Philadelphia and Drexel Hill, PA.
11:50am – 12:05pm
Laser Complications
As more laser procedures are being done, we should be aware of the potential complications and use techniques to minimize the risk of complications.
Nazanin Saedi, MD, Assistant Professor of Department of Dermatology and Cutaneous Biology and Director of Laser Surgery and Cosmetic Dermatology at Thomas Jefferson University, Philadelphia, PA.
12:05pm – 12:20pm
Leg Vein Disease: A Dermatologist’s Perspective on a Dermatologic Disease
Chronic venous insufficiency(CVI) affects 2-5% of Americans. Many sequelae of CVI manifest in the skin. Consequently, dermatologists often are on the front line of diagnosis and management. This talk will review the basic epidemiology, pathophysiology, and presentations of CVI and aims to familiarize the audience with the management of symptomatic vein disease as well as cosmetic sclerotherapy.
Todd V. Cartee, MD, Assistant Professor of Dermatology at Penn State Hershey Medical Center, Hershey, PA.
12:20pm – 12:30pm
Question & Answer
12:30pm – 12:50pm
Discussion of Top 3 Atlantic Derm Posters | Moderators: Lisa K. Pappas-Taffer, MD, and Temitayo A. Ogunleye, MD | Liberty Ballroom A/B
Poster Presenters | Daria Marley Kemp, MD; Daniel Lozeau, MD; Joyce Kim, MD
12:50pm – 12:55pm
Poster Question & Answer
12:55pm – 1:00pm
Closing Remarks | Mark Abdelmalek, MD, Overall Chairperson and Ellen J. Kim, MD, Program Director